BACKGROUND AND OBJECTIVES: In many countries, whole blood (WB) donations with collection times between 12 and 15 min are not allowed to be used for platelet concentrates (PC). Since the development of guidelines, many process-related changes have been introduced. We aimed to determine the effect of WB with long collection times on PC quality. MATERIALS AND METHODS: Five participating centres tested buffy coat (BC)-derived PC in platelet additive solution type E prepared from only WB collections lasting <12 min (control) versus similar PC including one BC from a collection lasting >12 min (study group, n = 8). One centre produced platelet-rich plasma (PRP)-derived PC from single donations (<10 or >12 min). All PC were stored at 22 ± 2°C and sampled on Days 1, 6 and 8 post-collection for in vitro quality determination. RESULTS: Average collection time was significantly longer in the study group compared to controls (8.9 ± 2.6 vs. 7.3 ± 1.3 min, p < 0.001). There were no differences in volume, platelet concentration, basal CD62P expression, soluble-CD62P and CCL5 levels, or nucleotide content between the groups. Stimulation with TRAP-6 resulted in comparable levels of cell surface CD62P. On Day 8, all PC fulfilled requirements for pH. The findings from single PRP-derived PC centre were similar. CONCLUSION: PC with one BC and single PRP derived from collections lasting >12 min had equivalent in vitro quality to controls during storage. This study provides evidence that 12-15 min donations should not be excluded for PC preparation and justifies to readdress the guidelines to <15 min instead of <12 min of collection in line with current practice in some countries.

Blood Bank Product and Process Development Sanquin Blood Supply Amsterdam The Netherlands

German Red Cross Blood Service NSTOB Springe Germany

Haematology Biochemistry and Blood Transfusion Military University Hospital Prague Prague Czech Republic

Hospital Israelita Albert Einstein São Paulo Brazil

Irish Blood Transfusion Service Dublin Ireland

Research and Development Australian Red Cross Blood Lifeblood Sydney New South Wales Australia

Zobrazit více v PubMed

European Directorate for the Quality of Medicines & HealthCare: Guide to the preparation, use and quality assurance of blood components. 20th ed. Strasbourg: Council of Europe Publishing; 2020.

Cohn CS, Delaney M, Johnson ST, Katz LM. Technical manual. 20th ed. Bethesda: AABB; 2020.

Blood and blood components, National Standard of Canada, CAN/CSA-Z902-20. Standards Council of Canada, 4th edition, 2020, Toronto: CSA Group.

Guidelines for the Blood Transfusion Services in the UK, 8th edition, 2013, Norwich: TSO. [cited 2021 Dec 14]. https://www.transfusionguidelines.org/red-book

Reiss RF, Katz AJ. Platelets and factor VIII as functions of blood collection time. Transfusion. 1976;16:229-31.

Huh YO, Lichtiger B, Giacco GG, Guinee VF, Drewinko B. Effect of donation time on platelet concentrates and fresh-frozen plasma. An in vitro study. Vox Sang. 1989;56:21-4.

Bontekoe IJ, Groot S, Sijbrands D, van der Meer PF, Lagerberg JW, de Korte D. Single-donor platelet concentrates from whole blood donations with collection drawing times between 12 and 15 minutes. Abstract. Vox Sang. 2017;112(S1):136.

Middelburg RA, Roest M, Ham J, Coccoris M, Zwaginga JJ, van der Meer PF. Flow cytometric assessment of agonist-induced P-selectin expression as a measure of platelet quality in stored platelet concentrates. Transfusion. 2013;53:1780-7.

Wood B, Johnson L, Hyland RA, Marks DC. Maximising platelet availability by delaying cold storage. Vox Sang. 2018;113:403-11.

Gravemann U, Volgmann T, Min K, Philipp R, Lambrecht B, Müller TH, et al. In vitro variables of buffy-coat derived platelets concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions. Transfusion. 2015;55:1700-9.

Bontekoe IJ, van der Meer PF, Verhoeven AJ, de Korte D. Platelet storage properties are associated with age: in vitro quality of platelets from young donors and older donors with and without type 2 diabetes. Vox Sang. 2019;114:129-36.

Kunicki TJ, Tuccelli M, Becker GA, Aster RH. A study of variables affecting the quality of platelets stored at “room temperature”. Transfusion. 1975;15:414-21.

Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Transfusion. 1998;38:31-40.

Bontekoe IJ, van der Meer PF, van den Hurk K, Verhoeven AJ, de Korte D. Platelet storage performance is consistent by donor: a pilot study comparing “good” and “poor” storing platelets. Transfusion. 2017;57:2373-80.

de Korte D, Haverkort WA, Roos D, van Gennip AH. Anion-exchange high performance liquid chromatography method for the quantitation of nucleotides in human blood cells. Clin Chim Acta. 1985;148:185-96.

Johnson L, Coorey CP, Marks DC. The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion. 2014;54:1917-26.